Main Article Content
Abstract
Background: Type 2 Diabetes Mellitus (Type 2 DM) is a metabolic disease whose prevalence continues to increase and can cause various complications, one of which is diabetic nephropathy, which can lead to kidney failure.
Objective: To evaluate the association of sociodemographic and clinical factors of diabetic type 2 patients with HbA1c and eGFR.
Methods: A cross-sectional study was conducted among 170 diabetic patients at community pharmacies in Yogyakarta from January 2022 to January 2023. Data were collected from patients' medication records, laboratory results of HbA1c, creatinine, eGFR, and structured questionnaires. A Chi-square test was performed to analyze group differences in categorical variables.
Results: Duration of diabetes mellitus (p = 0.021), comorbid hypertension (p = 0.040), and diabetes medication therapy (p < 0.001) were associated with good HbA1c control. Serum creatinine levels were significantly associated with age (p < 0.001). Age (p < 0.001), BMI (p = 0.039), education (p = 0.022), duration of diabetes (p = 0.044), and hypertension comorbidity (p = 0.040) were the factors that affected eGFR. However, no significant correlation was found between HbA1c and serum creatinine (r = 0.114; p = 0.134) or between HbA1c and eGFR (r = 0.026; p = 0.739).
Conclusion: There is no significant correlation between glycemic control (HbA1c) and renal function markers (serum creatinine and eGFR) in type 2 diabetic patients.
Keywords
Article Details
Copyright (c) 2026 Menit Ardhiani, Yosi Febrianti, Vitarani Dwi Ananda Ningrum, Diani Puspa Wijaya
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish in the Jurnal Ilmiah Farmasi agree to the following terms:
- Authors retain copyright and grant Jurnal Ilmiah Farmasi right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Ilmiah Farmasi.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Ilmiah Farmasi.
